Nobel Prize in chemistry awarded to two women who developed CRISPR, a revolutionary gene-editing tool
By Ben Guarino,
Washington Post
| 10. 07. 2020
A pair of scientists — Jennifer A. Doudna, a biochemist at the University of California at Berkeley, and Emmanuelle Charpentier, a French microbiologist — won the 2020 Nobel Prize in chemistry Wednesday for their work developing a revolutionary gene-editing tool that can change the DNA of plants and animals with extraordinary precision. The technique, called CRISPR -Cas9, is already being used as a cancer therapy and to cure inherited diseases.
“This year’s prize is about rewriting the code of life,” said Goran K. Hansson, secretary general of the Royal Swedish Academy of Sciences.
This was the first time two women jointly won a Nobel in chemistry. “I wish that this will provide a positive message, specifically, to young girls who would like to follow the path of science,” Charpentier told reporters Wednesday morning.
“I’m over the moon, I’m in shock, I couldn’t be happier,” Doudna said at a University of California at Berkeley news conference. She said she and Charpentier are “waving to each other across the Atlantic right now.”
Francis Collins, director of the National Institutes of Health, said...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...